An immunogenic composition comprising: (i) a conjugated pneumococcal capsular saccharide and (ii) a meningococcal factor H binding protein (fHBP) antigen, and not including meningococcal outer membrane vesicles, is useful for immunising a subject against bacterial meningitis.